NCT05476874

Brief Summary

This study is a phase I/IIa, single-center, open-labeled, randomized, controlled clinical trial. The aim of this study is to evaluate the safety and efficacy of a modified ventriculoperitoneal catheter placement using a splitable trocar for ventriculoperitoneal shunt.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 27, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

August 1, 2022

Status Verified

July 1, 2022

Enrollment Period

1.5 years

First QC Date

July 21, 2022

Last Update Submit

July 27, 2022

Conditions

Keywords

HydrocephalusVentriculoperitoneal ShuntDistal shunt failureTrocarComplications

Outcome Measures

Primary Outcomes (2)

  • Rate of shunt failure

    Overall rate of shunt failure requiring revision

    6 months

  • Duration of the abdominal catheterization

    Duration of the abdominal catheterization, defined as the time from abdominal incision to abdominal skin suture completed.

    During the surgery

Secondary Outcomes (5)

  • Rate of distal shunt failure

    6 months

  • The incidence of adverse reactions

    6 months

  • Abdominal incision size

    During the surgery

  • The incidence of anargesic drug use

    Day 5 after surgery

  • Duration of hospita stay

    During perioperative period

Study Arms (2)

Open Mini-laparotomy Group (OLG)

ACTIVE COMPARATOR

Distal shunt placement through open mini-laparotomy.

Procedure: Open Mini-Laparotomy

Abdominal Puncture Group (APG)

EXPERIMENTAL

Distal shunt placement through abdominal puncture.

Procedure: Abdominal Puncture

Interventions

A 5-cm paraumbilical skin is made, and the abdominal wall is incised in layers. The distal catheter tip is inserted into the peritoneal cavity in a craniocaudal direction, and the abdominal wound is sutured in layers.

Open Mini-laparotomy Group (OLG)

An about 0.5-cm paraumbilical incision made to allow introduction of a splitable trocar. The trocar is pierced through the abdominal wall into the abdominal cavity. Pull out the puncture cone, and adjust the trocar towards the pelvis. The distal catheter tip is inserted into the peritoneal cavity through the puncture cannula. Then the splitable puncture cannula is split apart and removed. The skin incision requires only one stitch.

Abdominal Puncture Group (APG)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or older with new-onset hydrocephalus, including obstructive hydrocephalus, traffic hydrocephalus and special types of hydrocephalus, normal pressure hydrocephalus (NPH), idiopathic intracranial hypertension (IIH), benign intracranial hypertension, pseudotumor cerebri, etc., regardless of gender.
  • Initial diagnosis of hydrocephalus requiring ventriculoperitoneal shunt or shunt failure requiring secondary surgery to replace the shunt.
  • Provided written informed consent.

You may not qualify if:

  • Previous abdominal surgery (except ventriculoperitoneal shunt).
  • Pregnancy
  • Peritonitis
  • Patients with cognitive impairment and inability to communicate.
  • Expected survival less than 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhujiang Hospital, Southern Medical University

Guangzhou, Guangdong, 510282, China

RECRUITING

Related Publications (3)

  • Schucht P, Banz V, Trochsler M, Iff S, Krahenbuhl AK, Reinert M, Beck J, Raabe A, Candinas D, Kuhlen D, Mariani L. Laparoscopically assisted ventriculoperitoneal shunt placement: a prospective randomized controlled trial. J Neurosurg. 2015 May;122(5):1058-67. doi: 10.3171/2014.9.JNS132791. Epub 2014 Dec 23.

  • Gravbrot N, Aguilar-Salinas P, Walter CM, Dumont TM. Laparoscopically Assisted Ventriculoperitoneal Shunt Placement Is not Cost-Effective nor Preventive for Distal Shunt Malfunction. World Neurosurg. 2020 May;137:e308-e314. doi: 10.1016/j.wneu.2020.01.193. Epub 2020 Feb 3.

  • Lou M, Zhou G, Zhao Y. The application of improved abdominal wall punctures technique in ventriculoperitoneal shunt for hydrocephalus: a retrospective analysis versus open mini-laparotomy. Br J Neurosurg. 2018 Dec;32(6):650-652. doi: 10.1080/02688697.2018.1429564. Epub 2018 Jan 24.

MeSH Terms

Conditions

Hydrocephalus

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Zhen-Zhou Chen, Dr.

    Zhujiang Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhen-Zhou Chen, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 21, 2022

First Posted

July 27, 2022

Study Start

January 1, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

August 1, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations